Global acceleration in humanoid robots: US activity heating up, China's output expanding rapidly, and policy support strengthening
AI summary card
Global acceleration in humanoid robots: US activity heating up, China's output expanding rapidly, and policy support strengthening
Deutsche Bank believes the humanoid robot industry continued to accelerate in 2Q 2026, driven mainly by China's better-than-expected mass production, increased investment from US companies and AI giants, and policy catalysts in China, the US, and Japan.
- China's Ministry of Industry and Information Technology expects annual humanoid robot output to exceed 100,000 units in 2026, significantly above Deutsche Bank's previous estimate of about 40,000 units.
- US activity is heating up, including Agility's planned SPAC listing, Meta's acquisition of an embodied AI model startup, OpenAI's restart of robotics hiring, and NVIDIA's expansion of its China robotics team.
- AGIBOT and Figure AI demonstrated commercial feasibility through factory and warehouse livestreams, reinforcing the signal that humanoid robots are moving from proof of concept to real-world scenarios.
- On the policy side, China, Shanghai, the US, and Japan all saw key updates; among them, Shanghai plans to deploy 100,000 humanoid robots in local factories by 2030, while Japan aims to deploy 10 million AI robots by 2040.
- Within its APAC industrial coverage, Deutsche Bank prefers Hengli, Shuanghuan, Harmonic Drive, and Yaskawa, and is also watching Tesla- and Mobileye-related humanoid robot positioning.
Report interpretation
Overview
This report is the 2Q 2026 edition of Deutsche Bank's quarterly humanoid robot tracking series, focused on rising US activity, rapid capacity expansion in China, and stronger policy support. The report argues that the humanoid robot market is accelerating globally, with industry signals strengthening in parallel across corporate financing, technology team expansion, mass-production milestones, factory/warehouse livestream validation, and government policy targets.
Core views
The core views are: first, China's mass-production progress is clearly ahead of previous expectations, with official forecasts calling for output to exceed 100,000 units in 2026; second, US technology and robotics companies are accelerating entry or expansion, including Agility, Meta, OpenAI, and NVIDIA; third, real-world application validation is increasing, with AGIBOT and Figure AI's extended livestreams showing the commercial feasibility of factory quality inspection and warehouse sorting scenarios; fourth, policy catalysts span China, Shanghai, the US, and Japan, potentially driving a reassessment of demand, capital, and supply chains; fifth, the rapidly developing market is likely to boost component demand, benefiting certain robotics component and automation manufacturers.
Analysis framework
The report uses a quarterly pulse-tracking framework, summarizing corporate events, capacity and orders, policy targets, application-scenario validation, product-form evolution, and related stock preferences. It is not a single-company earnings forecast report, but rather an industry theme and policy update report.
Methodology notes
Track progress in the humanoid robot industry through 2Q news flow, company announcements, policy documents, and public information.
This method is suitable for fast-changing early-stage industries and is used to identify marginal changes in mass production, financing, policy, application validation, and supply-chain demand.
Compare policy targets and regulatory actions in humanoid robots and AI robots across China, Shanghai, the US, and Japan.
Policy can provide demand and funding support, but it can also bring trade restrictions and supply-chain risks, so both positive catalysts and geopolitical constraints need to be assessed.
Use humanoid robot OEM mass production and real-scenario deployment as leading indicators of upstream component demand growth.
The report believes rapid market development will increase component demand, benefiting certain industrial automation and robotics component manufacturers.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- HengliOne of Deutsche Bank's preferred names in its APAC industrial coverage
- Strengths
- Benefits from the supply-chain logic of rising demand for humanoid robot components; listed in the report as Buy-rated.
- Weaknesses
- The report summary does not provide the company's specific revenue contribution or order data from humanoid robot business.
- Comparison
- Included among Deutsche Bank's preferred APAC industrial names alongside Shuanghuan, Harmonic Drive, and Yaskawa.
- Risks
- Humanoid robot mass-production pace falls short of expectations, component price declines, and delays in customer validation.
- ShuanghuanOne of Deutsche Bank's preferred names in its APAC industrial coverage
- Strengths
- May benefit from expanding demand for key robotics components; listed in the report as Buy-rated.
- Weaknesses
- This report does not provide standalone financial forecasts or target-price changes.
- Comparison
- Listed as a preferred name together with Hengli, Harmonic Drive, and Yaskawa.
- Risks
- Industry mass production comes in below expectations, competition intensifies, and customer concentration and pricing pressure rise.
- Harmonic DriveOne of Deutsche Bank's preferred names in its APAC industrial coverage
- Strengths
- As a company related to precision robotics transmission, it may benefit from humanoid robot component demand.
- Weaknesses
- The report summary does not provide company-level orders or earnings sensitivity.
- Comparison
- Alongside Yaskawa, it is one of the Japanese robotics and automation-related beneficiary assets.
- Risks
- Volatility in Japanese and global robot demand, cost pressure, and valuation sensitivity to industry expectations.
- YaskawaOne of Deutsche Bank's preferred names in its APAC industrial coverage
- Strengths
- Has a strong foundation in industrial automation and robotics, and may benefit from Japan's AI robot strategy and global robot demand.
- Weaknesses
- The report does not provide detailed earnings forecast revisions in this note.
- Comparison
- Like Harmonic Drive, it is influenced by Japanese robotics industrial policy and manufacturing automation trends.
- Risks
- Industrial cycle downturn, robot investment implementation slower than policy targets, and competitive pressure.
- TeslaUS humanoid robot OEM-related name
- Strengths
- The report lists Tesla as a US humanoid robot OEM name to watch and marks it as Buy-rated.
- Weaknesses
- This report does not focus on Tesla Optimus details and lacks new operating data within this note.
- Comparison
- Along with Mobileye via Mentee Robotics, it is listed as a US humanoid robot OEM-related asset.
- Risks
- Product commercialization slower than expected, insufficient technology validation, and valuation already reflecting high thematic expectations.
- MobileyeRelated to the US humanoid robot OEM theme through Mentee Robotics
- Strengths
- The report lists Mobileye as Buy-rated and highlights it as a US humanoid robot OEM-related asset.
- Weaknesses
- This note does not provide detailed orders, mass-production, or financial data for Mentee Robotics.
- Comparison
- Belongs to the same US humanoid robot OEM theme focus as Tesla.
- Risks
- Uncertain contribution from related business, early-stage commercialization path, and market repricing of thematic relevance.
- META PLATFORMS INCParticipant in embodied AI model positioning
- Strengths
- Meta acquired Assured Robot Intelligence, and the ARI team will join Meta Superintelligence Labs to build humanoid robot intelligence.
- Weaknesses
- The transaction value was not disclosed, and the short-term financial impact is unclear.
- Comparison
- Like OpenAI and NVIDIA, it reflects the extension of US AI platform companies into robotics and embodied intelligence.
- Risks
- Long payback period on R&D investment, unclear commercialization path, and high difficulty in integrating AI with robotics.
- NVIDIAParticipant in robotics platforms and development ecosystem
- Strengths
- Expanded its China robotics team and launched the NVIDIA Isaac GR00T reference humanoid robot and development platform.
- Weaknesses
- Cooperation with Unitree faces uncertainty because Unitree was placed on the US Department of Defense Military Companies list.
- Comparison
- Compared with a single OEM, NVIDIA is more focused on platforms, chips, development ecosystems, and model infrastructure.
- Risks
- Geopolitical restrictions, partner compliance risks, and robot hardware mass-production pace slower than ecosystem expectations.
- AGIBOTChina humanoid robot mass-production and industrial-scenario validation company
- Strengths
- Cumulative output reached 15,000 units, and it demonstrated a 99.99% task success rate through a six-day factory quality-inspection livestream.
- Weaknesses
- Commercial order conversion, scaled delivery, and long-term reliability still need further validation.
- Comparison
- Alongside Figure AI, it uses livestreams to demonstrate the feasibility of real-world applications.
- Risks
- Quality control in scaled production, pace of customer deployment, and competition and pricing pressure.
- Figure AIUS warehouse humanoid robot application-validation company
- Strengths
- Completed a 200-hour autonomous livestream, handling about 250,000 parcels with no hardware failures, at speeds close to human levels.
- Weaknesses
- There are still handling issues such as dropped parcels or incorrect orientation.
- Comparison
- Together with AGIBOT, it represents application-validation samples for US warehouse sorting and China factory quality inspection, respectively.
- Risks
- Generalization to complex scenarios, hardware cost, and scaled customer adoption.
Key data
- China 2026 humanoid robot output targetMore than 100,000 unitsForecast by an MIIT official on July 7, 2026; significantly above Deutsche Bank's previous estimate of about 40,000 units.
- Deutsche Bank's previous estimate of China 2025 outputAbout 15,000 unitsIf 2026 exceeds 100,000 units, that would imply more than fivefold year-over-year growth.
- Shanghai 2030 deployment target100,000 humanoid robotsShanghai plans to integrate 100,000 humanoid robots into local factories by the end of the 15th Five-Year Plan period.
- Japan 2040 AI robot deployment target10 million unitsJapan's METI revised its AI Robotics Strategy, covering 18 high-demand industries.
- Japan Noetra five-year funding arrangementJPY1tnOf which dedicated FY2026 funding is JPY387bn.
- Agility valuation and financingPre-money valuation of US$2.5bn; expected financing of more than US$620mnAgility plans to go public through a SPAC merger with CCXI, with the post-transaction ticker expected to be AGLT.
- Agility supply chain localization ratioAbout 75%About 75% of Digit components are sourced domestically in the US.
- Agility Digit annual capacityUp to 10,000 units/yearThe company's existing manufacturing facilities are planned for annual capacity of up to 10,000 units.
- Agility Digit v5 ordersMore than US$300mnThe company disclosed that Digit v5 has received more than US$300mn in orders, with a potential pipeline several times that size.
- Agility BOM cost targetFrom US$125k down to US$30kThe goal is to achieve this BOM cost reduction at a production scale of 10,000 units per year.
- AGIBOT cumulative output15,000 unitsAs of June 28, 2026, AGIBOT announced the rollout of its 15,000th general-purpose embodied robot, the Genie G2.
- AGIBOT June livestream performance8 robots completed 17,625 tasks with a 99.99% success rateThe livestream covered the full tablet quality-inspection process at Longcheer Technology's Nanchang factory.
- Figure AI livestream performance200 hours, about 250,000 parcels, no hardware failuresThree Figure 03 robots conducted an autonomous livestream demonstration in humanoid-robot warehouse sorting tasks.
- UBTECH U1 Pro priceRMB169,800The U1 Pro is a full-body version with 88 degrees of freedom, but currently mainly supports static-pose interaction.
- UBTECH bionic robot ordersMore than 13,361 unitsCumulative orders exceeded 13,361 units by the end of June 2026, with delivery targeted within 2026.
- Kepler valuation and performanceValuation about RMB722mn; 2025 revenue RMB4.3mn, net loss RMB67mnHangzhou Kelin plans to acquire control of Kepler, whose internal target is FY2026 revenue of more than RMB100mn.
Impact & implications
From an investment perspective, humanoid robots are progressing from a thematic concept toward mass production, policy support, and real-scenario validation, which may increase market attention on robotics components, actuators, reducers, sensors, control systems, industrial automation, and embodied AI platforms. The report explicitly states that rapid market development signals rising component demand, benefiting component manufacturers; at the same time, potential US restrictions on imports of Chinese robots also indicate that supply-chain localization and geopolitical policy risks need to be incorporated into valuation judgments.
Risks
- The US may restrict imports of humanoid or quadruped robots made in China, creating trade and supply-chain uncertainty.
- Humanoid robots are still in a rapid iteration stage, and there are execution risks around mass production, reliability, cost reduction, and conversion of commercial orders.
- Some market news has not been confirmed by the companies, such as rumored internal projects and deployment volumes related to BYD and Li Auto, so official disclosures need to be distinguished from unconfirmed information.
- Companion-style bionic robots are expensive, with clear battery-life and functionality limitations, and demand in household scenarios still needs validation.
- Policy targets span a long cycle, and actual capital investment, enterprise deployment, and industry adoption rates may fall short of plans.
- The benefit logic for supply-chain companies depends on OEM mass-production pace; if end demand or robot application rollout slows, component demand may come in below expectations.
What to watch
- Whether the Agility-CCXI SPAC transaction is completed as planned before 4Q26, and the subsequent progress of financing and order conversion after AGLT lists.
- Monthly or quarterly realization of China's 2026 humanoid robot output target of more than 100,000 units.
- AGIBOT's planned deployment of about 100 units on the Longcheer production line in the third quarter, and the delivery pace of framework orders approaching one thousand units.
- Whether Figure AI's warehouse sorting task can move from livestream validation to scaled commercial deployment.
- Follow-up policy outcomes for the US GUARD Act and the Commerce Department's review of Chinese robot imports.
- Supporting policies, bidding, and factory rollout pace for Shanghai's plan to deploy 100,000 humanoid robots by 2030.
- Industrial coordination after Japan's Noetra plan, the JPY1tn funding arrangement, and the participation of 35 companies including Fanuc and Yaskawa.
- Subsequent compliance and commercial progress of the NVIDIA Isaac GR00T platform's cooperation with Unitree, LG, and others.
- Application effectiveness of embodied large models such as Alibaba Qwen-Robot and DobotWAM on real robot platforms.
- Whether UBTECH U1 series order deliveries, user feedback, and humanoid robot revenue contribution reach management targets.